Treatment Overview
Significant, clinically proven weight loss, supported by a programme designed to help you build habits that make results last.
Using licensed GLP-1 medications Wegovy and Mounjaro, our medically supervised programme works by regulating appetite, slowing digestion, and helping you feel fuller for longer. Patients have achieved an average weight loss of between 15 and 22% of body weight in clinical trials.
Medication alone is only part of the picture however. Our programme combines treatment with personalised guidance on nutrition, activity, and lifestyle. This gives you the tools to sustain your results long after you stop taking Wegovy or Mounjaro.
Book your weight loss consultation to learn if this treatment is right for you.
Key Benefits
Medical supervision
Personalized approach
Sustainable results
Health optimization
Ideal For
Weight management
Health improvement
Lifestyle change
Frequently Asked Questions
Your weight loss programme revolves around dietary and physical exercise guidance and advice complimentary to weight loss injections such as Ozempic, Wegovy, and Mounjaro. This is more of a complete lifestyle change assisted by medicine, rather than reliance on medicine.
This plan can help you reduce bodyweight if you are overweight on the BMI scale, as well as helping to control diabetes with Mounjaro specifically.
This works by combining healthy eating and physical activity habits, through guidance, with weight control medication.
You will see results from the first month, where most clients report a weekly reduction of 1kg-2kg in total bodyweight. This will continue as you continue to maintain healthier habits and use the medication. We advise slowly weaning off the medication when you are at a healthy bodyweight on the BMI scale.
This is suitable for you if you are overweight or obese on the BMI scale and have made the choice to reduce your bodyweight and live a healthier lifestyle. It's best for people who will make habit changes instead of relying entirely on the medication.
This is not suitable if you are already at a healthy weight, unless you have a diabetes diagnosis and would like to control it with Mounjaro. The medication is also not suitable if you are pregnant or breastfeeding, have severe gastrointestinal disease, a history of pancreatitis or gallbladder disease, severe kidney or liver disease, or sensitivity to the medication.
Ozempic and Wegovy are both the same medicine, under different names with different licensing. Ozempic is not licensed for weight loss, rather for diabetes management, whilst Wegovy is licensed for weight loss.
Mounjaro is different to Ozempic and Wegovy, with a different active ingredient called tirzepatide. It is also the only one licensed for both weight control and diabetes management.
All three have similar side effects with the most common being nausea, vomiting, upset stomach, diarrhoea or consitpation, and fatigue. You may experience these symptoms when starting but they begin to subside as your body adjusts to the medication. We recommend starting on the lowest doses and only increasing the dose if needed, to minimise the side effects.
Many people regain the weight lost after stopping the medication. This is an indirect result however as people find it more difficult to control calorie intake without the appetite suppression effect. This is why we focus on building healthier habits, and slowly weaning off the medication, to maintain your results even without the medication.
The medications each have similar risk profiles which, whilst uncommon, require medical attention. This can include pancreatitis, gallbladder problems, kidney issues, low blood sugar, and rare eye complications. If you're experiencing anything that feels in line with these risks, contact your provider immediately.